[Acute hepatitis caused by virus A, E and non A-E in Chilean adults]

Rev Med Chil. 2001 May;129(5):523-30.
[Article in Spanish]

Abstract

Background: Sanitary and socioeconomic changes and the identification of new causative virus, have changed the epidemiology of hepatitis in Chile.

Aim: To study the natural history of acute hepatitis caused by virus A, E and non A-E in Chilean adults.

Patients and methods: A special study protocol was followed for patients with a clinical picture of acute hepatitis. Anti HAV IgM, anti HBc IgM, anti HEV IgG and IgM and Anti HCV antibodies were determined by ELISA.

Results: Fifty nine patients (30 male), aged 15 to 58 years old were studied. Eighty nine percent had jaundice and 50 to 70% had malaise and abdominal pain. Virus A was positive in 80%, virus E in 7%. In 14% of patients, all viral markers were negative. The evolution was typical in 78%, biphasic in 14% and cholestatic in 5%. One patient had a prolonged and one a fulminant course. Mean ALT was 1148 U/l and mean total bilirubin was 5.5 mg/dl. Seventy three percent of cases occurred during early winter and spring and 27% during summer and early autumn.

Conclusions: The main etiology of acute viral hepatitis in Chile is virus A and most cases occur during the rainy season. Clinical features of hepatitis non A-E are similar to enteral transmission forms.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Chile / epidemiology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hepatitis A / epidemiology
  • Hepatitis A / immunology
  • Hepatitis A / virology
  • Hepatitis Antibodies / immunology
  • Hepatitis E / epidemiology
  • Hepatitis E / immunology
  • Hepatitis E / virology
  • Hepatitis Viruses / immunology
  • Hepatitis Viruses / isolation & purification*
  • Hepatitis, Viral, Human / epidemiology
  • Hepatitis, Viral, Human / immunology
  • Hepatitis, Viral, Human / virology*
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Seasons

Substances

  • Hepatitis Antibodies